Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. Purchases New Holdings in Astera Labs, Inc. $ALAB

Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 3,000 shares of the company’s stock, valued at approximately $499,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ALAB. Royal Bank of Canada increased its stake in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after acquiring an additional 95,409 shares during the period. AQR Capital Management LLC increased its stake in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after acquiring an additional 7,756 shares during the period. Empowered Funds LLC increased its stake in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares during the period. First Trust Advisors LP increased its stake in Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after acquiring an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its holdings in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Insider Transactions at Astera Labs

In other news, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. The trade was a 7.39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,316,257 shares of company stock valued at $474,860,636 in the last three months. 12.50% of the stock is owned by corporate insiders.

Astera Labs Price Performance

Shares of ALAB opened at $349.17 on Friday. The company has a market capitalization of $59.85 billion, a P/E ratio of 235.93, a PEG ratio of 4.31 and a beta of 3.35. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $354.53. The business’s 50 day simple moving average is $186.48 and its 200-day simple moving average is $163.86.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have weighed in on ALAB. Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. JPMorgan Chase & Co. lifted their price objective on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Morgan Stanley lifted their price objective on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Stifel Nicolaus lifted their price objective on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.